J. Cadranel (Paris Cedex 20, France), I. Tietzova (Praha, Czech Republic)
Late Breaking Abstract - Induction of the transcriptional repressor B lymphocytes-induced maturation protein-1 (Blimp-1) in lung cancer
L. Neurath (Erlangen, Germany), D. Trufa (Erlangen, Germany), C. Geppert (Erlangen, Germany), R. Rieker (Erlangen, Germany), H. Sirbu (Erlangen, Germany), S. Finotto (Erlangen, Germany)
|     |
Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer
V. Bajoriunas (Kaunas, Lithuania), I. Bajoriuniene (Kaunas, Lithuania), E. Stankevicius (Kaunas, Lithuania)
| |
Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression
D. Ntenekou (Patras, Greece), P. Kastana (Patras, Greece), M. Hatziapostolou (Nottingham, United Kingdom), C. Polytarchou (Nottingham, United Kingdom), A. Marazioti (Patras, Greece), S. Nikou (Patras, Greece), G. Herradon (Madrid, Spain), E. Papadaki (Patras, Greece), G. Stathopoulos (Patras, Greece), C. Mikelis (Amarillo, TX, United States of America), E. Papadimitriou (Patras, Greece)
| |
LSC - 2020 - Comprehensive characterization of the immune landscape within different molecular subtypes of small cell lung cancer (SCLC)
A. Nuñez Buiza (Madrid, Spain)
| |
Prediction of long-term effect of anti-angiogenic therapy in lung cancer patients by monitoring early changes in circulating-tumor DNA (ctDNA).
M. Pešek (Plzen, Czech Republic), B. Lucie (Prague, Czech Republic), M. Svaton (Plzen, Czech Republic), B. Belsanova (Prague, Czech Republic), R. Ptackova (Prague, Czech Republic), O. Fiala (Pilsen, Czech Republic), M. Minarik (Prague, Czech Republic)
| |
Long-term prognosis of patients with cancer-related mutations in non-tumoral lung.
R. Chalela (Barcelona, Spain), K. Khilzi (Barcelona, Spain), J. Gea (Barcelona, Spain), A. Sánchez-Font (Barcelona, Spain), L. Pijuan (Barcelona, Spain), J. González-García (Barcelona, Spain), D. Badenes-Bonet (Barcelona, Spain), B. Bellosillo (Barcelona, Spain), V. Curull (Barcelona, Spain)
| |
Interactions of lung cancer with adipose and muscle tissue in the development of cancer cachexia
A. Frille (Leipzig, Germany), N. Linder (Leipzig, Germany), J. Pappisch (Leipzig, Germany), T. Kerkhoff (Leipzig, Germany), J. Meyer (Leipzig, Germany), H. Kuhn (Leipzig, Germany), C. Hänel (Leipzig, Germany), H. Busse (Leipzig, Germany), K. Steinhoff (Leipzig, Germany), M. Rullmann (Leipzig, Germany), T. Ebert (Leipzig, Germany), S. Krämer (Leipzig, Germany), J. Broschewitz (Leipzig, Germany), O. Sabri (Leipzig, Germany), S. Hesse (Leipzig, Germany), H. Seyfarth (Leipzig, Germany), H. Wirtz (Leipzig, Germany)
| |
Role of extracellular vesicles in chemotherapy-induced lung metastasis
N. Mansouri (Lausanne, Switzerland), I. Keklikoglou (Lausanne, Switzerland), S. Nassiri (Lausanne, Switzerland), B. Torchia (Lausanne, Switzerland), A. Guichard (Lausanne, Switzerland), M. De Palma (Lausanne, Switzerland)
| |
Exosomes from Intermittent Hypoxia Treated Lung Adenocarcinoma Cell Line Up-regulate Programmed Death Ligand 1 Expression through HIF-1a Pathway in Macrophages
y. liu (GuangZhou, China), X. Gao (GuangZhou, China), M. Lu (GuangZhou, China), J. Chen (GuangZhou, China), S. Li (GuangZhou, China)
| |